Related Title :
Inovio Receives Approval to Conduct Phase 3 COVID Vaccine Trial in Mexico
INOVIO receives regulatory approval to conduct Phase 3 efficacy study of its COVID-19 DNA vaccine candidate …
Inovio [NASDAQ: INO] receives approval to conduct phase 3 study of its COVID-19 vaccine

Ref: https://seekingalpha.com